Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Beta-S is a topical combination ointment containing betamethasone valerate (0.1% w/w) and salicylic acid (3% w/w). Developed by Deurali Janta Pharmaceuticals, it is indicated for the treatment of inflammatory and keratotic skin conditions, such as psoriasis, eczema, and dermatitis. Betamethasone valerate is a potent topical corticosteroid that reduces inflammation, redness, and itching by acting as a glucocorticoid receptor agonist. Salicylic acid is a keratolytic agent that softens and exfoliates the outer layer of the skin, which facilitates the penetration and absorption of the corticosteroid into the affected skin layers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on betamethasone valerate + salicylic acid.